Clinical Trial Update: A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update comparing two sequencing regimens of docetaxel, cisplatin, and gemcitabine in advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Platinol (cisplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: UNKNOWN